Thermo Fisher Scientific Heracell VIOS™ 250i AxD Incubator

Thermo Fisher Scientific introduces the Heracell™ VIOS™ 250i AxD CO2 Incubator, designed to enhance workflow automation in cell therapy production. This state-of-the-art incubator integrates seamlessly into automated and modular laboratories, ensuring precise cell growth conditions with minimal contamination risk.

The Heracell VIOS 250i AxD features a patent-pending automated door control system. This system allows the incubator door to open automatically when connected to a centralized lab automation platform, facilitating robotic loading and unloading of vessels. This innovation supports continuous cell therapy production processes and reduces the need for manual handling, which is crucial for maintaining sterility and reducing contamination risks.

Key specifications include:

• In-chamber HEPA filtration that captures particles of all sizes, safeguarding cultures from airborne contaminants introduced when the door opens.
• Thermo Scientific™ THRIVE™ active airflow, which ensures homogeneous culturing conditions throughout the incubator chamber.
• The Thermo Scientific Steri-Run™ Cycle, capable of achieving a 12-log sterility assurance level, which eliminates over one million biological indicators in half the time typically required for dry heat and autoclave sterilization.

These features make the Heracell VIOS 250i AxD particularly suitable for cell therapy manufacturers, biotech firms, and pharmaceutical companies focused on advancing therapies for conditions such as cancer, autoimmune disorders, and orphan diseases. Automation of cell culture processes with the Heracell VIOS 250i AxD can significantly enhance production efficiency and product consistency, supporting the scalable manufacture of high-quality cell therapies.